Abstract:Janinne Ortega-Montiel, 1 Luis A Martinez-Juarez, 1, 2 Alejandra Montoya, 1 Linda Morales-Juárez, 3 Héctor Gallardo-Rincón, 1, 4 Victoria Galicia-Hernández, 1 Rodrigo Garcia-Cerde, 1 María Jesus Ríos-Blancas, 1 Diego-Abelardo Álvarez-Hernández, 1 Julieta Lomelin-Gascon, 1 Gisela Martínez-Silva, 1 Lucía M Illescas-Correa, 5 Daniel A Diaz Martinez, 6 Francisco Javier Magos Vázquez, 6 Edwin Vargas Ávila, 6 Ma Concepción Carmona-Ramos, 7 Ricardo Mújica‐Rosales, 1 Enrique Reyes-Muñoz, 8 Roberto Tapia-Conyer 9 1 Carlos Slim Foundation, Mexico City, Mexico; 2 Johns Hopkins Center for Humanitarian Health, Bloomberg School of Public Health, Baltimore, MD, USA; 3 Institute for Obesity Research, Tecnológico de Monterrey, Mexico City, Mexico; 4 Health Sciences University Center, University of Guadalajara, Guadalajara, Jalisco, Mexico; 5 Maternal and Childhood Research Center (CIMIGEN), Mexico City, Mexico; 6 Ministry of Health of the State of Guanajuato, Tamazuca, Guanajuato, Mexico; 7 Ministry of Health of the State of Hidalgo, Pachuca, Hidalgo, Mexico; 8 Coordinatión of Gynecological and Perinatal Endocrinology, National Institute of Perinatology Isidro Espinosa de los Reyes, Mexico City, Mexico; 9 National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico Correspondence: Alejandra Montoya, Carlos Slim Foundation, Lago Zurich 245, Presa Falcon Building (Floor 20), Col. Ampliación Granada, Miguel, Hidalgo, Mexico City, 11529, Mexico, Tel +52 55 4976 0344, Email Purpose: This study explores the impact of gestational diabetes mellitus (GDM) subtypes classified by oral glucose tolerance test (OGTT) values on maternal and perinatal outcomes. Patients and Methods: This multicenter prospective cohort study (May 2019–December 2022) included participants from the Mexican multicenter cohort study Cuido mi Embarazo (CME). Women were classified into four groups per 75-g 2-h OGTT: 1) normal glucose tolerance (normal OGTT), 2) GDM-Sensitivity (isolated abnormal fasting or abnormal fasting in combination with 1-h or 2-h abnormal results), 3) GDM-Secretion (isolated abnormal values at 1-h or 2-h or their combination), and 4) GDM-Mixed (three abnormal values). Cesarean delivery, neonates large for gestational age (LGA), and pre-term birth rates were among the outcomes compared. Between-group comparisons were analyzed using either the t -test, chi-square test, or Fisher's exact test. Results: Of 2,056 Mexican pregnant women in the CME cohort, 294 (14.3%) had GDM; 53.7%, 34.4%, and 11.9% were classified as GDM-Sensitivity, GDM-Secretion, and GDM-Mixed subtypes, respectively. Women with GDM were older (p = 0.0001) and more often multiparous (p = 0.119) vs without GDM. Cesarean delivery (63.3%; p = 0.02) and neonate LGA (10.7%; p = 0.078) were higher in the GDM-Mixed group than the overall GDM group (55.6% and 8.4%, respectively). Pre-term birth was more common in the GDM-Sensitivity group than in the overall GDM group (10.2% vs 8.5%, respectively; p=0.022). At 6 months postpartum, prediabetes was more frequent in the GDM-Sensitivity group than in the overall GDM group (31.6% vs 25.5%). Type 2 diabetes was more common in the GDM-Mixed group than in the overall GDM group (10.0% vs 3.3%). Conclusion: GDM subtypes effectively stratified maternal and perinatal risks. GDM-Mixed subtype increased the risk of cesarean delivery, LGA, and type 2 diabetes postpartum. GDM subtypes may help personalize clinical interventions and optimize maternal and perinatal outcomes. Keywords: Gestational Diabetes, GDM-Mixed, GDM-Secretion, GDM-Sensitivity, macrosomia, cesarean delivery, pre-term delivery Gestational diabetes mellitus (GDM) is a heterogeneous disease that is identified during pregnancy. It is associated with multiple physiologic changes, including alterations to glucose metabolism, adverse maternal–perinatal outcomes, and long-term cardiometabolic consequences. 1,2 According to the Diabetes Atlas published by the International Diabetes Federation, the estimated global prevalence of GDM in 2021 was 16.7%, affecting an estimated 21 million births. Notably, the region encompassing North America and the Caribbean demonstrated a higher GDM prevalence of 20.7%, impacting approximately 1.3 million births. 3 In Mexico, the prevalence of GDM has been reported to be between 10%–12%, 4 and the multicenter cohort study Cuido mi Embarazo (CME) conducted in Mexico identified a GDM prevalence of 14%.<su -Abstract Truncated-

174-OR: Identification of Gestational Diabetes (GDM) Subtypes via Machine Learning and Associations with Perinatal Complications

A new classification method for gestational diabetes mellitus: a study on the relationship between abnormal blood glucose values at different time points in oral glucose tolerance test and adverse maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus

Early Prediction of High Risk Gestational Diabetes Mellitus <i>via</i> Machine Learning Models

Early Prediction of Gestational Diabetes Mellitus in the Chinese Population Via Advanced Machine Learning

OR18-06 Metabolomic And Genetic Architecture Of Gestational Diabetes Subtypes

Identification and validation of gestational diabetes subgroups by data-driven cluster analysis

109-OR: Physiologic Subtypes of Gestational Glucose Intolerance and Risk of Future Prediabetes

Subtypes of gestational diabetes and future risk of pre-diabetes or diabetes

Different subtypes of gestational diabetes mellitus are associated with distinct perinatal outcomes in twin pregnancies

Contribution of Gestational Diabetes Mellitus Heterogeneity and Prepregnancy Body Mass Index to Large-for-gestational-age Infants-a Retrospective Case-Control Study

Comparison of Machine Learning Methods and Conventional Logistic Regressions for Predicting Gestational Diabetes Using Routine Clinical Data: A Retrospective Cohort Study

Genetic Susceptibility, Mendelian Randomization, and Nomogram Model Construction of Gestational Diabetes Mellitus

Discrete placental gene expression signatures accompany diabetic disease classifications during pregnancy

Postpartum glucose intolerance after gestational diabetes mellitus: tailored prediction according to data-driven clusters and BMI-categories

Characteristics and pregnancy outcomes of subtypes of gestational diabetes mellitus based on HOMA-IR and BMI

1245-P: GDM Patients and Prognostic Factors for Subsequent Type 2 Diabetes Mellitus—An Electronic Cohort Review

Genetic Studies of Gestational Diabetes Mellitus in 21,813 Chinese Women

Gestational Diabetes Mellitus Subtypes Classified by Oral Glucose Tolerance Test and Maternal and Perinatal Outcomes: Results of a Mexican Multicenter Prospective Cohort Study "Cuido Mi Embarazo"

Heterogeneity of Gestational Diabetes and Risk for Adverse Pregnancy Outcome: A Cohort Study

Enhancing gestational diabetes mellitus risk assessment and treatment through GDMPredictor: a machine learning approach

Characteristics of gestational diabetes subtypes classified by oral glucose tolerance test values